Cargando…

Circulating Chromosome Conformation Signatures Significantly Enhance PSA Positive Predicting Value and Overall Accuracy for Prostate Cancer Detection

SIMPLE SUMMARY: Prostate cancer occurs in one out of six men during their lifetime. Because its symptoms are not specific, it is often diagnosed late. The widely used prostate-specific antigen (PSA) blood test does not have sufficient accuracy, resulting in numerous unnecessary prostate biopsies in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pchejetski, Dmitri, Hunter, Ewan, Dezfouli, Mehrnoush, Salter, Matthew, Powell, Ryan, Green, Jayne, Naithani, Tarun, Koutsothanasi, Christina, Alshaker, Heba, Jaipuria, Jiten, Connor, Martin J., Eldred-Evans, David, Fiorentino, Francesca, Ahmed, Hashim, Akoulitchev, Alexandre, Winkler, Mathias
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913359/ https://www.ncbi.nlm.nih.gov/pubmed/36765779 http://dx.doi.org/10.3390/cancers15030821

Ejemplares similares

Monocytes acquire prostate cancer specific chromatin conformations upon indirect co-culture with prostate cancer cells
por: Alshaker, Heba, et al.
Publicado: (2022)

Chromatin conformation changes in peripheral blood can detect prostate cancer and stratify disease risk groups
por: Alshaker, Heba, et al.
Publicado: (2021)

The emerging role of FTY720 (Fingolimod) in cancer treatment
por: White, Christopher, et al.
Publicado: (2016)

Sphingosine Kinase 1 in Breast Cancer—A New Molecular Marker and a Therapy Target
por: Alshaker, Heba, et al.
Publicado: (2020)

Development and Validation of Blood-Based Predictive Biomarkers for Response to PD-1/PD-L1 Checkpoint Inhibitors: Evidence of a Universal Systemic Core of 3D Immunogenetic Profiling across Multiple Oncological Indications
por: Hunter, Ewan, et al.
Publicado: (2023)

Leptin signalling, obesity and prostate cancer: molecular and clinical perspective on the old dilemma
por: Alshaker, Heba, et al.
Publicado: (2015)

Transcriptome-Wide Effects of Sphingosine Kinases Knockdown in Metastatic Prostate and Breast Cancer Cells: Implications for Therapeutic Targeting
por: Alshaker, Heba, et al.
Publicado: (2019)

Bradycardia and syncope as sole manifestations of a cranial lesion: a case report
por: Pchejetski, Dmitri, et al.
Publicado: (2020)

A case of severe dry eye disease with corneal melting as presenting complaint of acute myeloid leukaemia
por: Pchejetski, Dmitri, et al.
Publicado: (2021)

An unusual case of disseminated intravascular coagulation
por: Pchejetski, Dmitri, et al.
Publicado: (2017)

Everolimus (RAD001) sensitizes prostate cancer cells to docetaxel by down-regulation of HIF-1α and sphingosine kinase 1
por: Alshaker, Heba, et al.
Publicado: (2016)

Combination of RAD001 (everolimus) and docetaxel reduces prostate and breast cancer cell VEGF production and tumour vascularisation independently of sphingosine-kinase-1
por: Alshaker, Heba, et al.
Publicado: (2017)

Histone deacetylases as new therapy targets for platinum-resistant epithelial ovarian cancer
por: Pchejetski, Dmitri, et al.
Publicado: (2015)

New FTY720-docetaxel nanoparticle therapy overcomes FTY720-induced lymphopenia and inhibits metastatic breast tumour growth
por: Alshaker, Heba, et al.
Publicado: (2017)

Field template-based design and biological evaluation of new sphingosine kinase 1 inhibitors
por: Alshaker, Heba, et al.
Publicado: (2018)

Core shell lipid-polymer hybrid nanoparticles with combined docetaxel and molecular targeted therapy for the treatment of metastatic prostate cancer
por: Wang, Qi, et al.
Publicado: (2017)

Leptin induces upregulation of sphingosine kinase 1 in oestrogen receptor-negative breast cancer via Src family kinase-mediated, janus kinase 2-independent pathway
por: Alshaker, Heba, et al.
Publicado: (2014)

Perceived patient burden and acceptability of MRI in comparison to PSA and ultrasound: results from the IP1-PROSTAGRAM study
por: Eldred-Evans, David, et al.
Publicado: (2023)

Chromosome conformation signatures define predictive markers of inadequate response to methotrexate in early rheumatoid arthritis
por: Carini, Claudio, et al.
Publicado: (2018)

Identifying men affected by changes in PSA screening in the COVID-19 pandemic
por: Bass, E.J., et al.
Publicado: (2022)

Intra-Abdominal Pressure in the Early Phase of Severe Acute Pancreatitis: Canary in a Coal Mine? Results from a Rigorous Validation Protocol
por: Bhandari, Vimal, et al.
Publicado: (2013)

Initial Identification of a Blood-Based Chromosome Conformation Signature for Aiding in the Diagnosis of Amyotrophic Lateral Sclerosis
por: Salter, Matthew, et al.
Publicado: (2018)

The Prospective Study of Epigenetic Regulatory Profiles in Sport and Exercise Monitored Through Chromosome Conformation Signatures
por: Hall, Elliott C. R., et al.
Publicado: (2020)

Predictive factors for lymph node positivity in patients undergoing extended pelvic lymphadenectomy during robot assisted radical prostatectomy
por: Batra, Vikram, et al.
Publicado: (2015)

Temperature Control of psaA Expression by PsaE and PsaF in Yersinia pestis
por: Quinn, Joshua D., et al.
Publicado: (2019)

Adjusting for verification bias in diagnostic accuracy measures when comparing multiple screening tests - an application to the IP1-PROSTAGRAM study
por: Day, Emily, et al.
Publicado: (2022)

Utility of lung ultrasound for extravascular lung water volume estimation during cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
por: Mittal, Amit Kumar, et al.
Publicado: (2021)

Efficacy of the three-point cuff palpation technique in preventing endobronchial tube migration during positioning in robotic pelvic surgeries
por: Mittal, Amit K., et al.
Publicado: (2022)

Supraclavicular block evaluation in oncoorthopedic patients under general anesthesia using perfusion index: A prospective cohort study
por: Shah, Shagun Bhatia, et al.
Publicado: (2023)

IFN-γ, IL-17 and TGF-β involvement in shaping the tumor microenvironment: The significance of modulating such cytokines in treating malignant solid tumors
por: Alshaker, Heba A, et al.
Publicado: (2011)

Urinary PSA and Serum PSA for Aggressive Prostate Cancer Detection
por: Höti, Naseruddin, et al.
Publicado: (2023)

Prolonged PSA stabilization and overall survival following sipuleucel-T monotherapy in metastatic castration-resistant prostate cancer patients
por: Holl, Eda K., et al.
Publicado: (2019)

Low hemoglobin and PSA kinetics are prognostic factors of overall survival in metastatic castration-resistant prostate cancer patients
por: Hakozaki, Yuji, et al.
Publicado: (2023)

C-reactive protein haplotype is associated with high PSA as a marker of metastatic prostate cancer but not with overall cancer risk
por: Eklund, C M, et al.
Publicado: (2009)

Very Early PSA Response to Abiraterone in mCRPC Patients: A Novel Prognostic Factor Predicting Overall Survival
por: Facchini, Gaetano, et al.
Publicado: (2016)

Long-term prognostic significance of rising PSA levels following radiotherapy for localized prostate cancer – focus on overall survival
por: Freiberger, Carla, et al.
Publicado: (2017)

PSA Kinetics as Prognostic Markers of Overall Survival in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Abiraterone Acetate
por: España, Sofia, et al.
Publicado: (2020)

The Relationship between Prostate Biopsy Results and PSA and Free PSA Ratio Changes in Elevated Serum PSA Patients with and without Antibiotherapy
por: Duran, Mesut Berkan, et al.
Publicado: (2020)

Prognostic significance of a novel indicator (PSA(postd3)/PSA(pre)) for PSA recurrence in patients after radical prostatectomy
por: Zhou, Zhien, et al.
Publicado: (2019)

Use of Imaging to Optimise Prostate Cancer Tumour Volume Assessment for Focal Therapy Planning
por: Eldred-Evans, David, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_n44vubprvcbbobelefnea48gqr